Showing results (951-960 of 1,071) with videos related to

Sort By:
Pageof 108
International Journal of Cancer|April 19, 2013
Occupational exposure to arsenic and risk of nonmelanoma skin cancer in a multinational European studySimona Surdu, Edward F Fitzgerald, Michael S Bloom, et al.
Heliyon|August 22, 2024
Quality seed production scenario of Egyptian clover (<i>Trifolium alexandrinum</i>) in India: A 24-year retrospective analysisSubhash Chand, Ajoy Kumar Roy, Sanjay Kumar, et al.
American Journal of Blood Research|September 20, 2021
Safety and efficacy of splenectomy in immune thrombocytopeniaKundan Mishra, Suman Kumar, Rajeev Sandal, et al.
Lung India : Official Organ of Indian Chest Society|January 11, 2018
Efficacy of gefitinib in epidermal growth factor receptor-activating mutation-positive nonsmall cell lung cancer: Does exon 19 deletion differ from exon 21 mutation?Amit Joshi, Vijay Patil, Vanita Noronha, et al.
Ecancermedicalscience|November 7, 2017
Impact of exon 19 versus exon 21 EGFR-activating mutation on outcomes with upfront pemetrexed-carboplatin chemotherapyVanita Noronha, Vijay Patil, Amit Joshi, et al.
Plos One|November 26, 2015
Expression Patterns and Potential Biological Roles of Dip2aLuqing Zhang, Humphrey A Mabwi, Norberto J Palange, et al.
Chemotherapy Research and Practice|December 5, 2017
Efficacy of Second-Line Pemetrexed-Carboplatin in EGFR-Activating Mutation-Positive NSCLC: Does Exon 19 Deletion Differ from Exon 21 Mutation?Amit Joshi, Vanita Noronha, Vijay M Patil, et al.
The International Journal of Artificial Organs|July 9, 2021
Do anti-platelet drugs improve duration of continuous renal replacement therapy? A retrospective cohort study in cardiac ICU patientsVivek Gupta, Naved Aslam, Shibba Takkar Chhabra, et al.
Journal of Medicinal Chemistry|November 16, 2022
Discovery of Anthranilic Acid Derivatives as Difluoromethylornithine Adjunct Agents That Inhibit Far Upstream Element Binding Protein 1 (FUBP1) FunctionAiste Dobrovolskaite, Holly Moots, Mukund P Tantak, et al.
Exploration of Targeted Anti-Tumor Therapy|September 16, 2024
Correction: Deep learning based automated epidermal growth factor receptor and anaplastic lymphoma kinase status prediction of brain metastasis in non-small cell lung cancerAbhishek Mahajan, Gurukrishna B, Shweta Wadhwa, et al.
Pageof 108